LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-los ...

Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...

F45 Training Holdings Inc., a leading global fitness community known for innovative, high-energy group workouts, announced ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...